CorVel Co. (NASDAQ:CRVL) Chairman V Gordon Clemons sold 1,000 shares of CorVel stock in a transaction on Friday, September 21st. The stock was sold at an average price of $59.68, for a total transaction of $59,680.00. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

V Gordon Clemons also recently made the following trade(s):

  • On Monday, September 24th, V Gordon Clemons sold 1,000 shares of CorVel stock. The stock was sold at an average price of $58.54, for a total transaction of $58,540.00.
  • On Monday, September 17th, V Gordon Clemons sold 1,000 shares of CorVel stock. The stock was sold at an average price of $60.13, for a total transaction of $60,130.00.
  • On Wednesday, September 19th, V Gordon Clemons sold 3,000 shares of CorVel stock. The stock was sold at an average price of $60.11, for a total transaction of $180,330.00.
  • On Thursday, September 6th, V Gordon Clemons sold 2,000 shares of CorVel stock. The stock was sold at an average price of $59.75, for a total transaction of $119,500.00.
  • On Wednesday, August 29th, V Gordon Clemons sold 2,500 shares of CorVel stock. The stock was sold at an average price of $60.22, for a total transaction of $150,550.00.
  • On Friday, August 24th, V Gordon Clemons sold 802 shares of CorVel stock. The stock was sold at an average price of $60.32, for a total transaction of $48,376.64.
  • On Wednesday, August 22nd, V Gordon Clemons sold 2,000 shares of CorVel stock. The stock was sold at an average price of $60.03, for a total transaction of $120,060.00.
  • On Monday, August 20th, V Gordon Clemons sold 2,000 shares of CorVel stock. The stock was sold at an average price of $59.43, for a total transaction of $118,860.00.
  • On Tuesday, August 14th, V Gordon Clemons sold 3,000 shares of CorVel stock. The stock was sold at an average price of $57.60, for a total transaction of $172,800.00.
  • On Monday, August 6th, V Gordon Clemons sold 2,000 shares of CorVel stock. The stock was sold at an average price of $56.95, for a total transaction of $113,900.00.

CRVL opened at $60.05 on Thursday. The firm has a market capitalization of $1.14 billion, a P/E ratio of 29.63 and a beta of 0.65. CorVel Co. has a 12 month low of $46.45 and a 12 month high of $61.20.

CorVel (NASDAQ:CRVL) last posted its quarterly earnings data on Tuesday, July 31st. The business services provider reported $0.62 EPS for the quarter. The business had revenue of $150.40 million for the quarter. CorVel had a net margin of 6.78% and a return on equity of 23.42%.

Separately, BidaskClub raised shares of CorVel from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 17th.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Piedmont Investment Advisors LLC bought a new stake in CorVel in the 2nd quarter valued at $121,000. SG Americas Securities LLC lifted its position in CorVel by 66.0% in the 2nd quarter. SG Americas Securities LLC now owns 3,446 shares of the business services provider’s stock valued at $186,000 after acquiring an additional 1,370 shares in the last quarter. Barclays PLC lifted its position in CorVel by 60.8% in the 1st quarter. Barclays PLC now owns 6,231 shares of the business services provider’s stock valued at $315,000 after acquiring an additional 2,355 shares in the last quarter. Eqis Capital Management Inc. bought a new stake in CorVel in the 2nd quarter valued at $437,000. Finally, Allianz Asset Management GmbH lifted its position in CorVel by 87.9% in the 1st quarter. Allianz Asset Management GmbH now owns 10,437 shares of the business services provider’s stock valued at $528,000 after acquiring an additional 4,883 shares in the last quarter. 44.78% of the stock is currently owned by institutional investors and hedge funds.

About CorVel

CorVel Corporation provides medical cost containment and managed care services to address the medical costs of workers' compensation benefits, automobile insurance claims, and group health insurance benefits. The company offers network solutions, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review.

See Also: Buyback

Insider Buying and Selling by Quarter for CorVel (NASDAQ:CRVL)

Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.